Legend Creatives CO. Ltd. Pharmaceutical Import Profile — Myanmar (DGFT 2022–2026)

Name: Legend Creatives CO. Ltd. Pharmaceutical Import Records from India — 3 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Legend Creatives CO. Ltd. — Pharmaceutical Importer Profile (2026) | 3 Products, $500.0K Trade | TransData Nexus

Legend Creatives CO. Ltd.

Pharmaceutical Importer · Myanmar · Antifungals Focus · $500.0K Total Trade · DGFT Verified

Legend Creatives CO. Ltd. is a pharmaceutical importer based in Myanmar with a total trade value of $500.0K across 3 products in 2 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Legend Creatives CO. Ltd. sources from 3 verified Indian suppliers, with Multico Exports Private Limited accounting for 88.5% of imports.

Legend Creatives CO. Ltd. — Import Portfolio & Supplier Network

Legend Creatives CO. Ltd. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Legend Creatives CO. Ltd.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Multico Exports Private Limited	$892.5K	62	88.5%
Nabros Pharma Private Limited	$80.2K	7	8.0%
Unicure Remedies Private Limited	$35.3K

What Formulations Does Legend Creatives CO. Ltd. Import?

Formulation	Value	Ships
Clindamycin phosphate gel USP 1% w/w	$117.8K	3
Clotrimazole cream BP 1% w/w	$106.1K	4
Clobetasol propionate cream usp0.05 %	$104.6K	4
Betamethasone dipropionate cream USP	$104.2K	4
Ciprofloxacin ophthalmic solution USP	$104.0K	3
Miconazole nitrate cream BP (americon	$102.4K	3
Chloramphenicol eye ointment BP 1%	$101.5K	3
Dolaren tablets Each tablet contains	$52.5K	2
Ibuprofen 200MG.+paracetamol tablets 325MG (parbufen) tablets (unit Pack: 10 x 10 tablets)	$29.4K	2
Aciclovir cream BP (ambevir cream) (unit Pack: 10 GM tube)	$15.8K	2
Ibuprofen 200MG.+paracetamol tablets	$14.3K	1
Paracetamol syrup 60 ML Each 5ML	$12.0K	1
Clindamycin phosphate gel USP ? 1% w/w	$10.7K	1
Gentamicin sulphate ophthalmic	$7.8K	2
Hydroquinone cream u.s.p. 2% w/w (fairnyx cream) (unit Pack: 15 g tube)	$7.1K	4

Legend Creatives CO. Ltd. imports 51 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clotrimazole	Antifungals	$200.0K	4	0.2%	15
2	Clindamycin	Antibiotics	$150.0K	3	0.2%	9
3	Miconazole	Antifungals	$150.0K	3	0.8%	6

Legend Creatives CO. Ltd. imports 3 pharmaceutical products across 2 categories into Myanmar totaling $500.0K.

Legend Creatives CO. Ltd. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Legend Creatives Co. Ltd., established in 1998, is a prominent pharmaceutical importer and distributor based in Yangon, Myanmar. The company specializes in the marketing and distribution of finished pharmaceutical products, including tablets, capsules, syrups, injections, and skin creams, across the entire Myanmar market. Operating alongside its sister company, Wut Hmone Trading Co. Ltd., Legend Creatives has solidified its position as one of Myanmar's leading pharmaceutical distributors.

The company's headquarters are located at No. (138/142), First Floor, Thein Phyu Road, Botahtaung Township, Yangon, Myanmar. This strategic location facilitates efficient distribution throughout the country. Legend Creatives is part of a group of companies that also includes Wut Hmone Trading Co. Ltd., Asia Winner Industrial Co. Ltd., and May Yu Marine Products Co. Ltd., reflecting a diversified business portfolio.

2Distribution Network

Legend Creatives Co. Ltd. has developed an extensive distribution network to ensure comprehensive coverage of Myanmar's pharmaceutical market. The company operates a head office in Yangon, which oversees the Lower Myanmar area, and a branch office in Mandalay, covering Upper Myanmar. Additionally, it maintains sales branches and dealer networks in major cities such as Pathein, Mawlamyaing, Myeik, Sittwe, Pyinmanar, Yamethin, Pyi, Magwe, Taunggyi, Lashio, Myintkyinar, and Kalay. This widespread presence enables Legend Creatives to effectively serve both urban and rural regions across the country.

3Industry Role

In Myanmar's pharmaceutical supply chain, Legend Creatives Co. Ltd. functions primarily as a wholesaler and distributor. The company imports finished pharmaceutical formulations from various international suppliers, including India, and distributes these products to hospitals, clinics, pharmacies, and other healthcare providers throughout Myanmar. By acting as an intermediary between international manufacturers and local healthcare providers, Legend Creatives plays a crucial role in ensuring the availability of essential medications across the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Legend Creatives CO. Ltd.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Legend Creatives Co. Ltd. demonstrates a high degree of sourcing concentration, with a total import value of $500,000 USD from India over 10 shipments, covering three products across two therapeutic categories. The top three products imported are Clotrimazole ($200,000, Rank #15, 0.2% share), Clindamycin ($150,000, Rank #9, 0.2% share), and Miconazole ($150,000, Rank #6, 0.8% share). This concentration indicates a strategic focus on specific products, potentially leveraging favorable pricing or quality from Indian suppliers. However, such dependency on a single source may pose risks related to supply chain disruptions, currency fluctuations, or geopolitical issues affecting trade relations. The shipment data suggests a stable relationship with Indian suppliers, as evidenced by the consistent import volumes and product types over the period. Nonetheless, diversifying the supplier base could mitigate potential risks associated with over-reliance on a single country.

2Supply Chain Resilience

The resilience of Legend Creatives Co. Ltd.'s supply chain is closely tied to its reliance on Indian suppliers. The company imports finished pharmaceutical formulations, including Clotrimazole, Clindamycin, and Miconazole, from Indian manufacturers. While the consistent import data indicates a stable relationship, the lack of backup suppliers for these products suggests potential vulnerabilities. The company's focus on a limited number of formulations may expose it to risks if there are disruptions in the Indian supply chain, such as manufacturing issues, regulatory changes, or logistical challenges. Additionally, the absence of alternative suppliers for these specific products could impact the company's ability to maintain consistent product availability in the Myanmar market.

Importing Pharmaceuticals into Myanmar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Myanmar

1Regulatory Authority & Framework

In Myanmar, the Food and Drug Administration (FDA Myanmar), under the Ministry of Health, serves as the primary regulatory authority overseeing the import, manufacture, and distribution of pharmaceutical products. The National Drug Law, enacted in 1992 and amended subsequently, provides the legal framework governing these activities. This legislation outlines the requirements for drug registration, licensing, quality assurance, labeling, and advertising. For instance, it mandates that all pharmaceutical products must be registered with the FDA Myanmar before importation, ensuring they meet safety, efficacy, and quality standards. (servicetrade.gov.mm)

2Import Licensing & GMP

Import licensing in Myanmar requires that pharmaceutical products be registered with the FDA Myanmar prior to importation. This process involves submitting a dossier in the ASEAN Common Technical Dossier (ACTD) format, which includes administrative, quality, non-clinical, and clinical data. For imported products, mandatory documents include the Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, and a Letter of Authorization (LOA) from the manufacturer. Recognized GMP certifications include those from the European Union (EU GMP), World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, companies must obtain a wholesale distribution authorization to operate legally within Myanmar.

Legend Creatives CO. Ltd. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Legend Creatives Co. Ltd. focuses on importing antifungal and antibiotic formulations, with the top three products being Clotrimazole, Clindamycin, and Miconazole. This strategic focus aligns with the company's objective to meet the significant demand for these therapeutic categories in Myanmar. The high import values and consistent shipment data suggest a stable market demand for these products. The choice to import these specific therapeutic areas may be driven by factors such as prevalent health conditions in Myanmar, existing market gaps, and the company's established relationships with suppliers of these products.

2Sourcing Profile

Legend Creatives Co. Ltd. primarily sources generic pharmaceutical formulations from India, focusing on antifungal and antibiotic products. The company's sourcing strategy emphasizes cost-effectiveness and reliability, leveraging India's established pharmaceutical manufacturing capabilities. By importing finished formulations rather than active pharmaceutical ingredients (APIs) or bulk drugs, Legend Creatives ensures a streamlined supply chain and compliance with Myanmar's regulatory requirements for finished products.

3Market Positioning

Seller's Guide — How to Become a Supplier to Legend Creatives CO. Ltd.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Legend Creatives Co. Ltd., particularly in the areas of antifungal and antibiotic formulations. The company's existing focus on these therapeutic categories and its established import patterns indicate a stable demand. Potential gaps in Legend Creatives' current sourcing include the need for additional suppliers to mitigate risks associated with over-reliance on a single source and

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Legend Creatives CO. Ltd.

What products does Legend Creatives CO. Ltd. import from India?

Legend Creatives CO. Ltd. imports 3 pharmaceutical products across 2 categories. Top imports: Clotrimazole ($200.0K), Clindamycin ($150.0K), Miconazole ($150.0K).

Who supplies pharmaceuticals to Legend Creatives CO. Ltd. from India?

Legend Creatives CO. Ltd. sources from 3 verified Indian suppliers. The primary supplier is Multico Exports Private Limited (88.5% of imports, $892.5K).

What is Legend Creatives CO. Ltd.'s total pharmaceutical import value?

Legend Creatives CO. Ltd.'s total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Legend Creatives CO. Ltd. focus on?

Legend Creatives CO. Ltd. imports across 2 categories. The largest: Antifungals (70.0%), Antibiotics (30.0%).

Get Full Legend Creatives CO. Ltd. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.